MolNFT v1 · #167240 · protein
Human insulin in complex with the human insulin microreceptor in turn in complex with fv 83-7
6VEP · Insulin chain a: “Human insulin in complex with the human insulin microreceptor in turn in complex with fv 83-7”. X-ray diffraction, 4 ligands (NAG, FUC, BMA), 20 pockets (best druggability 0.85). MolNFT v1 #167240 on GenesisL1: 3D…
- PDB
- 6VEP
- Type
- protein
- Length
- 2,371 residues
- Chains
- 24
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Insulin chain a; Insulin B chain; Fv 83-7 heavy chain; Fv 83-7 light chain; Insulin…
- EC
- 2.7.10.1
- UniProt
- P01308, P06213
- Ligands
- NAG, FUC, BMA, MAN
- Pockets
- 20 · best druggability 0.85
Structure
x-ray diffraction · 16 distinct chains · 10% helix, 36% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, G, M, S | Insulin chain a | protein | 21 | 48% helix, 5% strand | P01308 |
| B | Insulin B chain | protein | 27 | 37% helix, 4% strand | P01308 |
| C | Fv 83-7 heavy chain | protein | 121 | 5% helix, 46% strand | — |
| D | Fv 83-7 light chain | protein | 116 | 3% helix, 48% strand | — |
| E | Insulin receptor subunit alpha (EC 2.7.10.1) | protein | 293 | 12% helix, 31% strand | P06213 |
| F, L, R, X | Insulin receptor subunit beta (EC 2.7.10.1) | protein | 16 | 56% helix, 0% strand | P06213 |
| H | Insulin B chain | protein | 25 | 40% helix, 4% strand | P01308 |
| I, U | Fv 83-7 heavy chain | protein | 117 | 8% helix, 48% strand | — |
| J | Fv 83-7 light chain | protein | 113 | 3% helix, 51% strand | — |
| K | Insulin receptor subunit alpha (EC 2.7.10.1) | protein | 294 | 11% helix, 32% strand | P06213 |
| N, T | Insulin B chain | protein | 26 | 38% helix, 4% strand | P01308 |
| O | Fv 83-7 heavy chain | protein | 122 | 5% helix, 46% strand | — |
| P | Fv 83-7 light chain | protein | 114 | 3% helix, 51% strand | — |
| Q | Insulin receptor subunit alpha (EC 2.7.10.1) | protein | 302 | 11% helix, 29% strand | P06213 |
| V | Fv 83-7 light chain | protein | 114 | 3% helix, 49% strand | — |
| W | Insulin receptor subunit alpha (EC 2.7.10.1) | protein | 296 | 11% helix, 32% strand | P06213 |
Ligands and binding sites
- NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 32 copies · chains E, C, G, K, I, Q, O, W, U, T, M
- FUC · alpha-L-fucopyranose · sugar · 9 copies · chains A, B, E, K, Q, W, S, T
- BMA · beta-D-mannopyranose · sugar · 8 copies
- MAN · alpha-D-mannopyranose · sugar · 2 copies
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
20 pockets found on a 1 Å grid, 10 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 986 | 0.85 | 0.86 | 114 | empty |
| 2 | 957 | 0.84 | 0.85 | 96 | empty |
| 3 | 941 | 0.75 | 0.79 | 82 | empty |
| 4 | 828 | 0.74 | 0.78 | 56 | empty |
| 5 | 783 | 0.66 | 0.74 | 53 | empty |
Interfaces
52 interfaces between chains.
- I–J · 868 Ų buried · 16 hydrogen bonds · protein-protein
- O–P · 866 Ų buried · 16 hydrogen bonds · protein-protein
- U–V · 866 Ų buried · 14 hydrogen bonds · protein-protein
- C–D · 850 Ų buried · 10 hydrogen bonds · protein-protein
- A–B · 714 Ų buried · 9 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 76 disulfide, 20 glycan (disulfide, N-glycosylation).
Compared structures
- 6VEP · Human insulin in complex with the human insulin microreceptor in turn in complex with Fv… · the same entry in another collection · chain J against J, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P01308
- Every structure of UniProt P06213
- Elsewhere: RCSB PDB 6VEP · PDBe 6VEP · UniProt P01308 · UniProt P06213
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.